Pinnacle Financial Group, Inc.’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Pinnacle Financial Group, Inc.'s CORT Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 40 shares worth $4.61K. The stake represents ﹤0.01% of the portfolio and ranks #1804 among its holdings.
497 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Pinnacle Financial Group, Inc. held 40 shares of Corcept Therapeutics worth $4.61K as of Q3 2026.
- Corcept Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Corcept Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1804 holding.
- 497 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.